To Die or Not to Die: How Sublethal Damage Rewires Cell Fate and Implications for Sepsis Authors: Zihan Hu, Xing Zhou, Qin Sun, Lianlian Jiang, Mengfan Wu, Jianfeng Xie, Yi Yang, Fei Peng Published: 2026 ABSTRACT AbstractLytic cell death has long been regarded as an irreversible process culminating in plasma membrane rupture. However, accumulating evidence indicates that the activation of lytic pathways does not invariably result in cell lysis. Instead, cells can undergo sublethal membrane damage, a state in which membrane injury is limited, allowing cells to remain viable while triggering persistent inflammation, barrier dysfunction and other functional alterations. This potentially reversible state may provide a therapeutic window in which limiting membrane rupture or enhancing membrane repair could preserve viable but compromised cells. This review focuses on the three major forms of lytic cell death: pyroptosis, necroptosis, and ferroptosis. We summarize the canonical molecular mechanisms, processes of membrane injury, regulatory pathways, and consequences of sublethal membrane damage. Furthermore, we discuss the shared features and biological impacts of sublethal membrane damage. Given the heterogeneous responses in sepsis, sublethal membrane damage may provide a relevant framework for understanding sepsis pathophysiology. A deeper understanding of this intermediate state may offer novel strategies for sepsis that aim not only to prevent complete cell lysis but also to modulate the function of viable but compromised cells. Introduction Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.1 It remains the leading cause of death worldwide, with an estimated 166 million cases of sepsis and 21.4 million sepsis-related deaths in 2021.2 As defined by Sepsis-3, organ dysfunction is central to sepsis, highlighting the importance of understanding how cellular injury contributes to organ failure. Despite decades of research, the mechanisms linking infection to multiple organ failure remain incompletely understood. A persistent paradox in sepsis is that the severity of organ dysfunction often appears disproportionate to the extent of the histopathological impairment. Hotchkiss et al found that the percentage of cell death did not correlate with severe organ dysfunction.3,4 This observation is reinforced by a study by Takasu et al. They confirmed a low level of apoptotic cardiomyocytes in septic patients.5 Yang et al also demonstrated that barrier failure occurs without cell death during sepsis.6,7 Moreover, host responses to sepsis are highly heterogeneous, indicating that stress signals in sepsis are spatially or temporally different.8 These findings raise the possibility that organ failure in sepsis is driven not only by irreversible cell death but also by an intermediate state of injury that remains incompletely defined. Cell death is traditionally defined as the degeneration of vital cellular functions and loss of integrity of the plasma membrane.9 Since apoptosis is recognized as a regulated form of cell death, an expanding spectrum of programmed cell death (PCD) has been identified, including pyroptosis, ferroptosis, necroptosis and so on.10,11 Cell death has long been implicated as a major determinant of tissue injury and immune disorders in sepsis. However, the relationship between cell death signaling and organ failure remains unresolved.12 PCDs can be categorized into non-lytic and lytic forms, which are associated with different immunological responses. Non-lytic cell death, such as apoptosis, preserves the integrity of the plasma membrane and is therefore immunologically silent.13 In contrast, lytic cell death is often characterized by plasma membrane injury, leading to the release of damage-associated molecular patterns (DAMPs).14 In pyroptosis and necroptosis, membrane permeabilization is achieved through the formation of membrane pores conducted by gasdermin and mixed lineage kinase domain-like (MLKL) proteins. These pores led to osmotic swelling and membrane rupture.15–17 Similarly, ferroptosis involves iron-dependent peroxidation of membrane lipids, which can destabilize the plasma membrane.18 This review focuses on pyroptosis, necroptosis and ferroptosis because they represent three classical forms of regulated cell death, in which plasma membrane damage is a pivotal feature and is related to inflammatory responses. Importantly, they encompass mechanistically distinct forms of membrane injury, ranging from protein-mediated membrane permeabilization to peroxidation-driven membrane destabilization, so as to provide a useful framework for examining whether sublethal membrane damage is shared across distinct forms of cell death. Moreover, as these pathways couple membrane injury to inflammation, they are increasingly being recognized as a crucial source of DAMPs in sepsis. The plasma membrane serves as a decisive determinant of lytic cell death. Once rupture of the plasma membrane occurs, cell survival is compromised.19 Traditionally, disruption of the plasma membrane during lytic cell death has been viewed as a catastrophic and irreversible event. However, recent studies have identified an intermediate state between survival and complete rupture, referred to as sublethal membrane damage.20–22 Before membrane rupture, cells can activate membrane repair mechanisms to remove damaged membrane patches. For example, membrane injury induced Ca2+ influx recruits ESCRT-III complex to the damage region, where it promotes membrane repair and shedding of injured part to restore membrane integrity.21,23–25 Although membrane integrity is partially compromised, cells remain viable, secrete cytokines, and disrupt cell junctions.25,26 Within the heterogeneous septic microenvironment, cells frequently encounter subthreshold insults that activate cell death pathways without reaching the threshold for complete rupture. Under such conditions, sublethal membrane damage may provide a conceptual framework for bridging the gap between cell death and sepsis20 (Figure 1). Figure 1Plasma membrane states across the continuum of lytic cell death. From left to right, the schematic illustrates three stages of membrane integrity: 1) intact membrane homeostasis, characterized by preserved plasma membrane integrity and normal ion balance; 2) sublethal membrane damage, characterized by limited pore formation or localized membrane lesions, limited Ca2⁺ influx, engagement of membrane repair mechanisms (eg, ESCRT-III-mediated membrane repair and vesicle shedding), and a viable but stressed cell; and 3) terminal membrane rupture, characterized by extensive membrane damage, osmotic swelling, massive DAMPs release, and lytic cell death. Created with BioRender.com.A diagram illustrating three stages of cell membrane integrity. Stage 1, labeled ′Cell Homeostasis′, shows a healthy cell with ′Membrane Integrity′ and ′Normal Ion Balance′, featuring potassium and sodium ions. It states ′No Release of DAMPs′. Stage 2, ′Sublethal Membrane Damage′, depicts a sublethal cell with ′Limited Permeabilization′, showing calcium influx, ESCRT-III involvement, vesicle shedding and cytokine release. A scale balances ′Injury Burden′ and ′Repair Capacity′. Stage 3, ′Plasma Membrane Rupture′, illustrates terminal lysis with ′Severe Membrane Rupture′, ′Osmotic Swelling′ and ′Release of DAMPs′, leading to cell death. Each stage is visually represented with distinct cellular changes.Diagram of three stages of cell membrane integrity: homeostasis, sublethal membrane damage, plasma membrane rupture.Abbreviations: Ca2+, calcium ions; Na+, sodium ions; K+, potassium ions; DAMPs, damage-associated molecular patterns; ESCRT, endosomal sorting complex required for transport. Plasma membrane states across the continuum of lytic cell death. From left to right, the schematic illustrates three stages of membrane integrity: 1) intact membrane homeostasis, characterized by preserved plasma membrane integrity and normal ion balance; 2) sublethal membrane damage, characterized by limited pore formation or localized membrane lesions, limited Ca2⁺ influx, engagement of membrane repair mechanisms (eg, ESCRT-III-mediated membrane repair and vesicle shedding), and a viable but stressed cell; and 3) terminal membrane rupture, characterized by extensive membrane damage, osmotic swelling, massive DAMPs release, and lytic cell death. Created with BioRender.com. In this review, we summarize the canonical mechanisms of pyroptosis, ferroptosis, and necroptosis, with a particular emphasis on how these pathways compromise plasma membrane integrity and give rise to sublethal membrane damage. We then discuss sublethal membrane damage as a shared framework for lytic cell death, focusing on its common features, regulatory mechanisms, and consequences. Additionally, we explore its biological plausibility and potential relevance to sepsis. By comparing these distinct yet interconnected forms of cell death, we aim to provide a unified perspective on how membrane injury reshapes cell fate and may offer novel therapeutic targets for sepsis. Pyroptosis Pyroptosis is a lytic and highly inflammatory form of programmed cell death executed by pore-forming members of the gasdermin family.9 First observed in anthrax lethal toxin-induced macrophage death in 1986, pyroptosis is typically triggered by microbial infections or damage-associated signals.27–29 The term “pyroptosis” was formally introduced in 2001 by Cookson to describe inflammatory cell death.30 In contrast to apoptosis, pyroptosis is characterized by plasma membrane permeabilization. As pore formation can occur in a graded and sometimes limited manner, pyroptosis provides an excellent model for investigating sublethal membrane damage.16 Among the gasdermin family members, gasdermin D (GSDMD) is the most extensively studied executor and is therefore the primary focus of this section. Here, we summarize the canonical and non-canonical pathways of pyroptosis, mechanisms of membrane injury, and evidence and consequences of sublethal membrane damage in pyroptosis (Figure 2). Figure 2Sublethal membrane damage in pyroptosis. The left panel illustrates the canonical and non-canonical activation pathways of pyroptosis. The upper right panel shows complete pyroptosis, characterized by abundant pyroptotic pores, major ion fluxes, osmotic swelling, IL-1β/IL-18 release, and cell lysis. The lower right panel depicts sublethal pyroptosis, in which transient or low-level activation generates limited pyroptotic pores that are counterbalanced by ESCRT-dependent membrane repair, allowing cells to remain viable in a stressed state with persistent inflammatory signaling. Created with BioRender.com.The diagram illustrates pyroptosis activation pathways and outcomes. The left section shows the pyroptosis activation pathway with pathogen-associated molecular patterns and damage-associated molecular patterns leading to canonical and non-canonical activation. Canonical activation involves the inflammasome and caspase 1 activation, while non-canonical activation involves cytolic lipopolysaccharide and caspase 4, 5, 11 activation. Both pathways lead to gasdermin D and gasdermin D N-terminal formation, resulting in gasdermin D oligomers, osmotic swelling and NINJ1 involvement. The upper right section depicts complete pyroptosis with pyroptotic pores, ion fluxes, osmotic swelling, interleukin 1 beta and interleukin 18 release and cell lysis. The lower right section shows sublethal pyroptosis with vesicle shedding, endocytosis and ESCRT-III dependent membrane repair, allowing cell viability with persistent inflammatory signaling.Diagram of pyroptosis pathways: activation, complete, sublethal and related cellular processes.Abbreviations: PAMPs, pathogen-associated molecular patterns; DAMPs, damage-associated molecular patterns; LPS, lipopolysaccharide; GSDMD, gasdermin D; GSDMD-NT, gasdermin D N-terminal fragment; NINJ1, ninjurin-1; Ca2+, calcium ions; Na+, sodium ions; K+, potassium ions; IL-1β, interleukin-1β; IL-18, interleukin-18; ESCRT, endosomal sorting complex required for transport. Sublethal membrane damage in pyroptosis. The left panel illustrates the canonical and non-canonical activation pathways of pyroptosis. The upper right panel shows complete pyroptosis, characterized by abundant pyroptotic pores, major ion fluxes, osmotic swelling, IL-1β/IL-18 release, and cell lysis. The lower right panel depicts sublethal pyroptosis, in which transient or low-level activation generates limited pyroptotic pores that are counterbalanced by ESCRT-dependent membrane repair, allowing cells to remain viable in a stressed state with persistent inflammatory signaling. Created with BioRender.com. Canonical and Non-Canonical Pyroptotic Pathways The canonical pyroptotic pathway is initiated by inflammasome assembly, which leads to the activation of caspase-1 and GSDMD, as well as the processing of the pro-inflammatory cytokines IL-1β and IL-18. These events ultimately lead to membrane permeabilization and the release of inflammatory cytokines. Inflammasomes are caspase-activating complexes that play a crucial role in immunity.31 They are typically composed of pattern recognition receptors (PRRs, also known as immune sensors), adapter apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), and pro-caspase-1.29,32 In response to pathogen-associated molecular patterns (PAMPs) or DAMPs, PRRs are activated, nucleating ASC and caspase-1 to assemble inflammasomes.31,33,34 Pro-caspase-1 is then processed into active caspase-1, which cleaves GSDMD into an N-terminal fragment and C-terminal fragment.35,36 The liberated N-terminal fragment of GSDMD (GSDMD-NT) oligomerizes to form pores on the mitochondrial and plasma membranes, thereby inducing ion fluxes, cell swelling, and membrane permeabilization.37–41 In parallel, active caspase-1 processes pro-IL-1β and pro-IL-18 into mature forms.29,42 Finally, ninjurin-1 (NINJ1) is activated and mediates the plasma membrane rupture (PMR), thereby allowing the release of mature IL-1β and IL-18.43–49 In parallel, the non-canonical pathway is triggered by cytosolic lipopolysaccharide (LPS) and converges on the cleavage of GSDMD and membrane permeabilization. Mechanistically, caspase-4/5 in humans or their murine ortholog caspase-11 oligomerizes after binding to LPS through their N-terminal caspase recruitment domains (CARDs).50,51 This recognition process has been shown to be facilitated by guanylate-binding proteins (GBPs).52–55 Activated caspase-4/5/11 then cleaves GSDMD, generating GSDMD-NT, which oligomerizes and forms pores in the plasma membrane.56 In addition, GSDMD-mediated ion fluxes can secondarily activate canonical NLRP3-caspase-1 signaling.43 Recently, Shi et al demonstrated that activated human caspase-4 can directly cleave pro-IL-18 at the same tetrapeptide site as caspase-1.57 In addition to the canonical and non-canonical pathways, pyroptosis can also be induced through alternative mechanisms. For example, GSDME can be cleaved by caspase-3, thereby converting apoptotic signaling into pyroptosis.58 In addition, granzymes released by cytotoxic lymphocytes have been shown to cleave GSDMB and GSDME, whereas streptococcal pyrogenic exotoxin B (SpeB) can directly cleave GSDMA.59–61 Collectively, multiple pathways converge on gasdermin activation to induce pyroptosis. Gasdermin Pore Formation and Membrane Disruption Gasdermin pore formation is the execution step of pyroptosis, which links inflammatory signaling to plasma membrane permeabilization. In both the canonical and non-canonical pyroptosis pathways, activated caspases cleave the linker between the amino-terminal and carboxy-terminal domains of GSDMD. This cleavage relieves the autoinhibitory interaction exerted by the C-terminal domain and releases an active N-terminal fragment.36 GSDMD-NT subsequently binds to the inner leaflet of the plasma membrane via interactions with anionic lipids.16,39,40,56 Upon membrane binding, GSDMD-NT assembles into arc-, slit-, and ring-shaped structures. Current studies suggest that smaller arc- and slit-shaped oligomers may fuse into larger ring-shaped pores, indicating that these conformations may represent different stages of pore formation.32,39,62–64 Such structural heterogeneity may lead to different subsequent cellular outcomes, but whether specific pore conformations differ in their ability to repair remains unclear.64 The formation of pyroptotic pores initiates the transmembrane ion flux. These pores are largely non-selective, which allows for the efflux of potassium and the influx of calcium and sodium.37 Ionic exchange has important downstream consequences. For example, intracellular K+ is maintained at approximately 140 mM normally. When it drops to 70–90 mM, the NLRP3 inflammasome is activated, followed by ASC oligomerization and caspase-1 recruitment.65,66 Meanwhile, ions and water exchange induces osmotic swelling and increases plasma membrane tension, thereby promoting terminal membrane rupture. Under resting conditions, NINJ1 is maintained in an autoinhibited dimeric state. Upon activation, this autoinhibition is released and NINJ1 oligomerizes to promote membrane damage.45,47,48 Recent evidence further suggests that NINJ1 increases plasma membrane fragility and lowers the mechanical threshold required for rupture. However, NINJ1 alone is not sufficient for plasma membrane rupture, and additional mechanical stress is needed to complete membrane rupture. Thus, the interplay between NINJ1 and membrane tension may determine whether membrane injury remains limited or progresses to membrane rupture.49 Sublethal Pyroptotic Membrane Damage Although pyroptosis is typically regarded as a “one-way ticket” to cell death, emerging evidence indicates that pyroptotic signaling does not invariably culminate in complete lysis. Under certain circumstances, cells can survive despite limited membrane permeabilization, a phenomenon referred to as sublethal pyroptosis.28 In this state, cells exhibit pyroptotic pores on the plasma membrane and release inflammatory mediators, while retaining membrane integrity. Shkarina et al used optogenetically controlled cell death effectors (optoCDEs) to emulate a sublethal pyroptosis state.22 Cui et al further showed that glycine can uncouple activated pyroptosis signaling from complete cell lysis, thereby protecting cells from rupture and inducing a sublytic phenotype.44 Consistently, inhibition of NINJ1 prevents complete plasma membrane rupture and results in ballooned cell without lysis.49 In dendritic cells, oxidized phospholipids activate caspase-11 and induce IL-1 release without causing cell rupture.67 Likewise, Evavold et al demonstrated a non-lytic role for GSDMD, showing that phagocytes bearing GSDMD pores can secrete IL-1 while remaining viable under hyperactivated conditions.68 In neutrophils, the transient formation of pyroptotic pores permits the release of S100A8/S100A9 and subsequently promotes neutrophil recruitment to blood vessels.69 Recently, Otchere et al identified ALIX as a mediator of membrane repair that limits pyroptosis.24 Together, these findings support the existence of a “pyroptosis-to-survival” switch, in which cells can tolerate a limited burden of pore formation without progressing to complete lysis. The transition from pyroptosis to survival is under sophisticated regulation. Mechanistically, whether pyroptotic signaling proceeds to complete lysis or remains in a sublethal state appears to depend primarily on the balance between the burden of membrane pores and the capacity of the repair system, with additional cellular factors further modulating this pathway. ESCRT Machinery Mediated Membrane Repair A key mechanism enabling recovery from pyroptotic membrane injury is the endosomal sorting complex required for transport (ESCRT) machinery. It has been reported that cells can efficiently repair plasma membrane pores less than 100 nm via ESCRT machinery.70 During membrane damage, ESCRT-III components are recruited to the sites of membrane injury, where they facilitate shedding of the damaged membrane portions in the form of ectosomes.70,71 This process is driven by calcium influx through the membrane pores, which induces ESCRT-III assembly and membrane repair, thereby rescuing cells from death.23 During this process, ESCRT-III limits plasma membrane damage and allows pyroptotic cells to survive while still permitting the release of inflammatory mediators such as IL-1β. Additional molecules also participate in this repair process. The endolysosomal protein LITAF has been identified as a mediator of pyroptosis-induced membrane repair, acting downstream of the potassium efflux to activate ESCRT-dependent resealing.72 Similarly, the Ras GTPase-activating-like protein IQGAP1 functions as a bridge between GSDMD pores and ESCRT, promoting the release of exosomes containing GSDMD and inflammasome components, thereby dampening cell death.73 During transient pyroptosis in neutrophils, CHMP4B, a component of the ESCRT-III machinery, is also involved in the rapid repair of membrane pores.69 Insufficient GSDMD Activation The extent of pyroptosis is highly dependent on the quantity and persistence of the active pyroptotic pores. Sublytic levels of GSDMD-NT were insufficient to overwhelm membrane repair mechanisms and induce cell lysis, resulting in limited pore formation and sublethal membrane damage.25 When cells were stimulated with a single pulse of moderate-intensity light, some displayed moderate DRAQ7 influx and membrane blebbing, yet remained viable and eventually recovered to normal morphology. However, a second pulse of illumination was sufficient to induce robust pyroptosis in these cells.22 Similarly, in the early phase of pyroptosis, low levels of GSDMD-NT may fail to reach the threshold required for cell lysis, thereby producing a sublethal phenotype.74 Putative Modulatory Factors Although direct evidence linking these factors to sublethal pyroptosis is scarce, several other factors are known to modulate the efficiency of pyroptotic signaling. Metabolic regulators, including reactive oxygen species (ROS) and metabolites such as succinate and itaconate, have been shown to influence GSDMD activation.38,75–78 Post-translational modifications of GSDMD, including palmitoylation, deacetylation, phosphorylation, O-GlcNAcylation, and succination, provide further regulation.79–87 In addition, membrane lipid composition can modulate the affinity of GSDMD-NT for the plasma membrane, whereas pore dynamics and degradation of key components may further modulate pyroptotic signaling.32,39,40,56,88–90 Collectively, these factors potentially contribute to sublethal pyroptosis, but this remains hypothetical and requires to be explored in further studies. Functional Consequences of Sublethal Pyroptotic Injury Inflammatory Amplification Sublethal pyroptosis amplifies inflammatory responses without compromising cell viability. The formation of pyroptotic pores increases plasma membrane permeability and permits the release of pro-inflammatory mediators, even in cells that remain viable.22 Thus, sublethal pyroptosis may contribute to inflammatory amplification and pathogen clearance. Another study showed that upon sublethal GSDMD activation, cells exhibit reversible membrane damage and chemokines production.25 Under such conditions, cells became rounded and positive for SYTOX Green staining, yet reattached to the culture dishes and resumed clonal growth after removal of the stimulus. Mechanistically, membrane pores allow calcium influx at the damaged sites, which activates protein kinase C (PKC) signaling and subsequently engages the TAK1/IKKs and RelA/Cux1 to trigger chemokine expression.25 These chemokines can function as alarmins, recruiting and activating immune cells to the infection site, thereby promoting a rapid immune response. Barrier Dysfunction Sublethal pyroptosis may compromise barrier integrity in addition to its immunostimulatory effects. Increased plasma membrane permeability in parenchymal cells can promote immune cell extravasation and leakage into the tissues. A recent study showed that, during the early phase of LPS-induced sepsis, a subset of brain endothelial cells presented with increased plasma membrane permeability without lysis, allowing bidirectional molecular exchange and blood-brain barrier destruction. These endothelial cells displayed condensed nuclei and shrunken cell bodies, yet remained attached to the vessel wall. Importantly, the tight junctions between these cells were impaired, contributing to vessel leakage.26,74 These findings indicated that sublethal pyroptotic injury may impair barrier function in the absence of cell loss. Collectively, these results suggest that sublethal pyroptosis may function as a double-edged sword during infection. On the one hand, it preserves host defense by enabling release of cytokines and chemokines without immediate cell death. However, it induces the amplification of inflammation, which may lead to tissue injury and an increase in vascular leakage. Recognizing sublethal membrane damage as a biologically meaningful state may refine our understanding of pyroptosis during sepsis. Ferroptosis Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death driven by lipid peroxidation. It does not rely on caspase activation or pore-forming proteins but instead results from the accumulation of oxidized phospholipids that compromise membrane integrity.18,91,92 As lipid peroxidation proceeds in a graded manner, ferroptosis provides a suitable context for investigating sublethal membrane damage. This section first outlines the core molecular mechanisms of ferroptosis and the process leading to membrane injury and then examines the evidence and potential consequences of sublethal ferroptosis (Figure 3). Figure 3Sublethal membrane damage in ferroptosis. The left panel illustrates the core molecular pathway of ferroptosis. The upper right panel shows complete ferroptosis, characterized by extensive lipid peroxidation, severe plasma membrane destabilization, membrane rupture and release of DAMPs. The lower right panel depicts sublethal ferroptotic membrane damage, in which limited lipid peroxidation induces membrane fragility without catastrophic rupture, allowing cells to remain viable under ESCRT-mediated repair. Created with BioRender.com.The diagram illustrates ferroptosis, an iron-dependent cell death process. The left section shows the activation pathway, starting with cystine uptake via System X subscript c superscript minus, converting to cysteine, then to GSH and involving GPX4. Iron from TFR undergoes the Fenton reaction, producing hydroxyl radicals. Lipids convert to PUFA-PL via ASCL4 and LPCAT3, leading to lipid peroxidation. The upper right section depicts complete ferroptosis with ROS, membrane rupture and DAMPs release. The lower right section shows sublethal ferroptosis with limited lipid peroxidation, ESCRT-III repair and cytokine release.Ferroptosis diagram: activation, full/sublethal stages, lipid peroxidation, membrane impact.Abbreviations: GSH, glutathione; GPX4, glutathione peroxidase 4; Tf, transferrin; TFR, transferrin receptor; Fe2+, ferrous ions; Fe3+, ferric ions; H2O2, hydrogen peroxide; -OH, hydroxyl radical; PUFA, polyunsaturated fatty acid; ACSL4, acyl-CoA synthetase long-chain family member 4; PUFA-CoA, polyunsaturated fatty acyl-coenzyme A; LPCAT3, lysophosphatidylcholine acyltransferase 3; PUFA-PL, polyunsaturated fatty acid-containing phospholipids; NINJ1, ninjurin-1; Ca2+, calcium ions; Na+, sodium ions; K+, potassium ions; DAMPs, damage-associated molecular patterns; ESCRT, endosomal sorting complex required for transport. Sublethal membrane damage in ferroptosis. The left panel illustrates the core molecular pathway of ferroptosis. The upper right panel shows complete ferroptosis, characterized by extensive lipid peroxidation, severe plasma membrane destabilization, membrane rupture and release of DAMPs. The lower right panel depicts sublethal ferroptotic membrane damage, in which limited lipid peroxidation induces membrane fragility without catastrophic rupture, allowing cells to remain viable under ESCRT-mediated repair. Created with BioRender.com. Molecular Mechanisms of Ferroptosis Accumulation of labile iron is essential for the initiation of ferroptosis. Iron enters cells via transferrin and its receptor, whereas ferritinophagy releases additional intracellular iron.93,94 Excess labile iron generates ROS via the Fenton reaction.95 These free radicals attack membrane phospholipids containing polyunsaturated fatty acid (PUFA) and convert them into phospholipid hydroperoxides (PLOOH). Once initiated, lipid peroxidation propagates as a chain reaction, destabilizing the plasma membrane and ultimately leading to cell lysis.96 There are antioxidant systems that protect cells from ferroptosis, among which glutathione peroxidase 4 (GPX4) functions as the major enzyme that reduces phospholipid hydroperoxides to nontoxic phospholipid alcohols.97–99 GPX4 activity depends on glutathione (GSH), which is synthesized from cysteine imported through the system Xc-cystine/glutamate antiporter. Impairment of system Xc- reduces cysteine availability and depletes GSH, thereby compromises GPX4-dependent protection.96 In addition to lipid peroxidation and antioxidant failure, Ramos et al found that NINJ1 was required for the loss of plasma membrane integrity and release of DAMPs during ferroptosis.100 Membrane Vulnerability in Ferroptosis The hallmark of ferroptosis is iron-dependent peroxidation of PUFA-containing phospholipids within the plasma membrane. Labile iron-driven reactive lipid radicals promote the peroxidation of membrane lipids, especially those enriched in PUFA, increasing the fragility of the plasma membrane.101 This extensive lipid peroxidation disrupts the membrane integrity through multiple mechanisms. Oxidized phospholipids alter membrane fluidity and thickness, generating mechanical tension that activates mechanosensitive ion channels, such as Piezo1 and transient receptor potential (TRP) channels. This, in turn, induces the efflux of potassium and the influx of sodium. Meanwhile, Na+/K+-ATPase is impaired and further promotes the collapse of the transmembrane ion gradient and cell swelling.102 Collectively, these changes destabilize the plasma membrane and facilitate its rupture. Pedrera et al demonstrated the presence of nanopores with a radius of a few nanometers on the surface of cells undergoing ferroptosis, which may exacerbate osmotic disturbance and membrane destabilization.103 Sublethal Ferroptotic Membrane Damage Emerging evidence suggests that ferroptotic membrane damage, similar to pyroptosis, may also exist in the sublethal state. Under such conditions, although lipid peroxidation-induced membrane injury occurs, the integrity of the plasma membrane is not irreversibly lost. Tang et al described a sublethal state of cells between ferroptosis and survival, in which cells rounded up without lysis under ferroptotic stimulation and subsequently restored normal morphology after removal of inducers together with ferroptosis inhibition.104 Similarly, polyethylene glycols (PEGs) were shown to delay ferroptosis through the ESCRT-III system without influencing lipid peroxidation, resulting in a rounded but viable shape that is reversible after withdrawal of PEGs.103 However, direct evidence for sublethal ferroptosis remains scarce, and several mechanisms discussed in this part are currently hypothetical. ESCRT Machinery ESCRT-III promotes survival during ferroptotic stress. Ferroptosis is characterized by a sustained rise in cytosolic calcium levels, which precedes plasma membrane rupture and is thought to result from membrane lesions. Calcium influx triggers ESCRT-III assembly, enabling repair of the damaged membrane.103 Consistently, silencing of ESCRT-III components such as CHMP5 or CHMP6 increases cellular susceptibility to ferroptosis.105 Incomplete Activation of Lipid Peroxidation Incomplete lipid peroxidation may generate a sublethal state in which PLOOH accumulate but remain below the threshold required for catastrophic membrane rupture. Although indirect evidence is consistent with this possibility, it has not yet been validated as a direct mechanism underlying sublethal ferroptosis. Consistent with this, low concentrations of ferroptosis inducers, such as RSL3 or erastin, can trigger lipid peroxidation and inflammatory responses, while causing only a limited loss of cell viability.106 Insufficient Membrane Tension Another hypothetical possibility is that insufficient membrane tension may delay membrane rupture during ferroptotic stress. As osmotic swelling-related membrane tension contributes to cell rupture, the inhibition of Piezo1 and TRP channels substantially prevents cell lysis, suggesting that membrane rupture can be modulated in ferroptosis.102 Although these mechanisms do not directly prove the existence of a sublethal ferroptotic state, they support the possibility that membrane damage during ferroptosis may be reversible under specific conditions. Functional Consequences of Sublethal Ferroptotic Injury Direct evidence of the functional consequences of sublethal ferroptotic injury remains limited. Nevertheless, available studies have suggested that sublethal ferroptotic stress may exert biological effects. One potential consequence is the amplification of inflammatory signaling. For example, ferroptotic stress in microglia has been shown to induce cytokine release and transform astrocytes into neurotoxic phenotypes, thereby promoting non-cell-autonomous neuronal injury.106 Pedrera et al reported that sublethal ferroptosis enhances macrophage activation by upregulating the expression of CD14, linking sublethal ferroptosis to immune responses.103 These findings support the hypothesis that sublethal ferroptotic stress may propagate inflammation and tissue injury. Whether sublethal ferroptotic injury contribute to other forms of impairment remains unclear and warrants further investigation. Necroptosis Necroptosis is a regulated form of necrotic cell death that morphologically resembles necrosis, but is executed through a distinct signaling pathway dependent on MLKL, ultimately leading to plasma membrane rupture and release of DAMPs.9,107,108 The activation of MLKL occurs at varying intensities and is under complicated regulation. Therefore, necroptosis provides an appropriate model for the investigation of sublethal membrane damage. This section summarizes the canonical signaling pathway, mechanisms of membrane injury in necroptosis, and evidence and impacts of sublethal necroptosis (Figure 4). Figure 4Sublethal membrane damage in necroptosis. The left panel illustrates the canonical signaling pathway of necroptosis. The upper right panel shows complete necroptosis driven by strong RIPK3–MLKL signaling, extensive MLKL oligomerization and membrane engagement, severe permeabilization, and cell lysis. The lower right panel depicts sublethal necroptosis, in which low-level MLKL activation leads to limited membrane lesions that are counterbalanced by ESCRT-III-mediated repair, thereby allowing cell survival accompanied by production of cytokines and chemokines. Created with BioRender.com.The left panel illustrates the necroptosis activation pathway. It begins with TNF binding to TNFR1, leading to the recruitment of TRAF2 or TRAF5, TRADD, RIPK1 and cIAP1 or cIAP2. This activates RIPK1, FADD and Caspase-8. FasL binds to Fas and TRAIL binds to DR, also activating RIPK1, FADD and Caspase-8. dsRNA activates TLR3, leading to TRIF and RIPK3 activation. LPS activates TLR4, while Z-RNA from viruses activates ZBP1, both leading to RIPK3 activation. RIPK3 phosphorylates MLKL, which oligomerizes and engages the membrane, interacting with SIGLEC12. The upper right panel shows complete necroptosis with MLKL oligomerization, membrane engagement, osmotic swelling and release of DAMPs. The lower right panel depicts sublethal necroptosis with limited MLKL activation, membrane repair by ESCRT-III, vesicle shedding and release of cytokines and chemokines, allowing cell survival.Diagram of necroptosis pathways and outcomes including complete necroptosis and sublethal necroptosis with membrane repair.Abbreviations: TNF, tumor necrosis factor; TNFR1, tumor necrosis factor receptor 1; TRAF2/5, TNF receptor-associated factor 2/5; TRADD, TNF receptor-associated death domain; RIPK1, receptor-interacting serine/threonine-protein kinase 1; cIAP1/2, cellular inhibitor of apoptosis protein 1/2; FADD, Fas-associated death domain; FasL, Fas ligand; TRAIL, TNF-related apoptosis-inducing ligand; DR, death receptor; dsRNA, double-stranded RNA; TLR, Toll-like receptor; LPS, lipopolysaccharide; Z-RNA, Z-form RNA; TRIF, TIR domain-containing adapter-inducing interferon-β; ZBP1, Z-DNA-binding protein 1; RIPK3, receptor-interacting serine/threonine-protein kinase 3; MLKL, mixed lineage kinase domain-like protein; SIGLEC12, sialic acid-binding immunoglobulin-like lectin 12; Ca2+, calcium ions; Na+, sodium ions; K+, potassium ions; DAMPs, damage-associated molecular patterns; ESCRT, endosomal sorting complex required for transport. Sublethal membrane damage in necroptosis. The left panel illustrates the canonical signaling pathway of necroptosis. The upper right panel shows complete necroptosis driven by strong RIPK3–MLKL signaling, extensive MLKL oligomerization and membrane engagement, severe permeabilization, and cell lysis. The lower right panel depicts sublethal necroptosis, in which low-level MLKL activation leads to limited membrane lesions that are counterbalanced by ESCRT-III-mediated repair, thereby allowing cell survival accompanied by production of cytokines and chemokines. Created with BioRender.com. Molecular Mechanisms of Necroptosis Necroptosis can be triggered by diverse stimuli including tumor necrosis factor (TNF), Fas ligand (FasL), TRAIL, toll-like receptors (TLRs), and viral sensors.107 The core execution pathway is mediated by receptor-interacting serine-threonine kinase3 (RIPK3) and its downstream effector, MLKL.109,110 In the canonical pathway, deubiquitinated RIPK1 recruits and phosphorylates RIPK3, forming necrosome, and subsequently activating MLKL. RIPK3 can also be activated independently of RIPK1.111,112 In addition, Z-DNA binding protein 1 (ZBP1) and the TLR adaptor TRIF can directly interact with RIPK3 through the RIP homotypic interaction motif (RHIM) and promote its activation.113,114 Once activated, MLKL oligomerizes and translocates to the plasma membrane, where it disrupts membrane integrity, leading to osmotic swelling and, ultimately, plasma membrane rupture.115,116 MLKL Translocation and Membrane Engagement Upon RIPK3-dependent phosphorylation, MLKL undergoes conformational activation, enabling its translocation to the plasma membrane and subsequent oligomerization. Structurally, MLKL is composed of an N-terminal four-helix bundle (4HB) domain, a C-terminal pseudokinase domain, and a two-helix brace region in the middle.116 The N-terminal 4HB functions as an executioner of plasma membrane disruption, whereas the C-terminal pseudokinase region restrains the activity of 4HB. This brace region is crucial for interdomain communication and oligomerization.110,117–119 Following phosphorylation by RIPK3, MLKL exposes the 4HB domain and brace region, sequentially binding to phosphatidylinositol phosphate (PIP) on the inner leaflet of the plasma membrane.17,120,121 Subsequently, oligomerized MLKL forms pores that disrupt the ionic gradients and promote osmotic instability.122–124 A recent study further suggested that downstream of MLKL oligomerization, TMPRSS4-mediated cleavage of SIGLEC12 may contribute to complete plasma membrane rupture.125 Sublethal Necroptotic Membrane Injury Recent studies have indicated that necroptosis is not irreversible and can proceed in a sublethal manner under specific conditions. Gong et al described a sublethal necroptotic state, which manifests as cell rounding, increased release of chemokines, and preserved plasma membrane integrity.21,25 Another study identified a similar phenomenon in hepatocytes, linking sublethal necroptotic signaling to hepatocarcinogenesis.126 Multiple mechanisms underlie this “necroptosis-to-survival switch”. ESCRT Machinery Membrane repair systems play a central role in restraining damage during necroptotic signaling. Following plasma membrane injury, ESCRT-III removes the compromised fragments by shedding them as extracellular bubbles, thereby preserving cell integrity. The recruitment of ESCRT-III is triggered by calcium influx through membrane pores.21,23 By preventing progression from membrane permeabilization to catastrophic rupture, ESCRT-III enables cells to survive necroptotic signaling in a sublethal state rather than undergoing membrane rupture. Additional Regulatory Mechanisms Additional regulatory mechanisms also influence the “necroptosis-to-survival” switch. In hepatocytes with low RIPK3 expression, concurrent NF-κB activation promotes sublethal necroptosis rather than overt cell death.126 In addition, post-translational modifications and degradation pathways can also limit necroptosis. Multiple studies have shown that ubiquitination, PARylation, and acylation can restrain necroptotic signaling by promoting the degradation of RIPK1 and RIPK3 or by limiting the membrane accumulation of MLKL.127–132 FADD and caspase-8 constitute another important regulatory mechanism between apoptosis and necroptosis. The catalytic activity of caspase-8 restrains necroptosis, whereas loss of the catalytic activity of caspase-8 switch apoptosis to necroptosis.133,134 These findings raise the possibility that sublethal necroptosis might be redirected toward apoptosis. However, direct evidence demonstrating it remains lacking. Ionic conditions may also influence the necroptotic pathway, as sodium-free and calcium-free media both significantly inhibit membrane rupture.123,124 Collectively, these regulatory mechanisms may constrain different steps of necroptotic pathway, and thereby influence the outcome of necroptotic signaling. Functional Consequences of Sublethal Necroptotic Injury Inflammatory Signaling Sublethal necroptosis may serve as an immune response by promoting inflammatory signaling without immediate cell loss. Gong et al showed that cells surviving necroptotic membrane damage via ESCRT-III-mediated repair exhibit activation of NF-κB signaling, which drives the production of multiple chemokines.21,25 These chemokines can recruit immune cells to sites of injured tissue, indicating that sublethal necroptosis is not merely a halt in cell death but also an active mode of inflammatory communication. Tumor Progression Sublethal necroptosis may also exert tumor-promoting effects in specific pathological contexts. A previous study demonstrated that hepatocytes undergoing sublethal necroptosis develop leaky membranes while preserving mitochondrial membrane potential. It not only allows sustained cytokine release but also delays necroptosis of tumor cells, thus promoting hepatocarcinogenesis.126 Collectively, sublethal necroptosis may reshape the host response in multiple ways. It contributes to immune surveillance and inflammatory signaling, and paradoxically promotes tumorigenesis. Given its significant impact on tissue homeostasis, future research on the molecular regulation of this incomplete form of cell death is warranted. Sublethal Membrane Damage as a Unifying Concept in Lytic Cell Death Characteristics and Shared Mechanisms of Sublethal Membrane Damage Sublethal membrane damage represents an intermediate state in which the plasma membrane is compromised by lytic executioners but does not progress to catastrophic rupture, thereby allowing cells to remain viable and retain the capacity to recover.20 In contrast to the traditional view of plasma membrane rupture, sublethal membrane damage challenges the “one-way ticket” theory of cell death. Several features characterize the sublethal membrane damage. First, membrane injury is localized, transient, or limited so that the cells do not collapse immediately.25,69 Second, limited membrane injury is accompanied by transmembrane ion fluxes, including Ca2⁺ and Na⁺ influx and K⁺ efflux, which disturb cellular homeostasis.21 Due to membrane lesions, sublethal cells are permeable to small molecules.69 Third, the repair system is activated upon injury, which temporarily preserves the membrane integrity and vital functions of cells.23 The mechanisms of membrane repair include patching, exocytosis, endocytosis, cytoskeletal contraction, self-sealing, ESCRT-mediated shedding, and reduction of membrane tension.135,136 Membrane repair is initiated within 1–2 minutes, followed by membrane remodeling over the next few minutes.137–140 Thus, the fate of injured cells is determined by complex regulation of injury and repair. Cellular Responses and Fate Determination After Sublethal Membrane Damage Cells that experience sublethal membrane injury are not functionally inert. Instead, they activate a coordinated stress response that includes inflammatory signaling, degradation of cell junction proteins, and long-term tissue remodeling. A key early event is the transmembrane ion flux. A previous study illustrated that non-selective ion flux occurs even earlier than propidium iodide uptake.37 Following these ion fluxes, inflammatory signaling pathways such as NF-κB and MAPK are activated, leading to the transcription of cytokines and chemokines, thus amplifying inflammation.25,141 Meanwhile, pore formation and repair could directly or indirectly impair tight junctions, further contributing to vascular leakage.74 In the long term, immune cells recruited by sublethal injuries may further promote tissue fibrosis and carcinogenesis.126 Beyond these stress responses, the fate of cells undergoing sublethal damage appears to be governed by the dynamic balance between injury and repair. When membrane injury remains limited and repair mechanisms are rapidly mobilized, cells may fully recover and restore their membrane integrity. For example, following optogenetically induced sublethal pyroptotic stimulation, a subset of cells exhibited blebbing, but subsequently reattached and resumed normal morphology.22 Another outcome is persistence in a sublethal but viable state. Transient activation of inflammasomes leads to short-lived pyroptotic pores on the plasma membrane, resulting in sublethal pyroptosis and the release of inflammatory mediators.69 However, when the burden of membrane injury exceeds the capacity of the repair system, catastrophic membrane rupture results in irreversible cell death. Thus, the fate of cells following membrane injury is not predetermined but is dynamically regulated by the balance between injury burden and repair capacity. The quantitative dose-response relationship and underlying mechanisms remain poorly defined and warrant further research (Figure 5). Figure 5Proposed role of sublethal membrane damage in sepsis. The left panel depicts the septic microenvironment, characterized by heterogeneous stimuli including PAMPs/DAMPs, cytokines, complement, ROS, and activation of multiple lytic pathways. The center panel shows a stressed but viable cell exhibiting limited GSDMD pores, partial MLKL-mediated membrane lesions, oxidized membrane lipids, and active membrane repair. The right panel illustrates the potential downstream consequences in immune cells (persistent cytokine release and immune dysregulation) and parenchymal cells (junctional disruption and barrier failure). Created with BioRender.com.The diagram illustrates the role of sublethal membrane damage in sepsis. On the left, the septic microenvironment includes PAMPs, DAMPs, cytokines, complement, reactive oxygen species, hypoxia and metabolic stress, leading to limited pores and membrane oxidation in a sublethal cell. The center shows a stressed cell with ion flux, vesicle shedding and endosome activity, involving ESCRT-III and calcium. On the right, downstream consequences in immune cells include persistent cytokine release and immune dysregulation. In parenchymal cells, effects include tight junction disruption and vascular leakage, with occludin and claudin involvement.Diagram showing sublethal membrane damage in sepsis, including the septic microenvironment, a sublethal cell, and downstream consequences.Abbreviations: PAMPs, pathogen-associated molecular patterns; DAMPs, damage-associated molecular patterns; ATP, adenosine triphosphate; ROS, reactive oxygen species; O2, molecular oxygen; Ca2+, calcium ions; ESCRT, endosomal sorting complex required for transport; GSDMD, gasdermin D; MLKL, mixed lineage kinase domain-like protein Proposed role of sublethal membrane damage in sepsis. The left panel depicts the septic microenvironment, characterized by heterogeneous stimuli including PAMPs/DAMPs, cytokines, complement, ROS, and activation of multiple lytic pathways. The center panel shows a stressed but viable cell exhibiting limited GSDMD pores, partial MLKL-mediated membrane lesions, oxidized membrane lipids, and active membrane repair. The right panel illustrates the potential downstream consequences in immune cells (persistent cytokine release and immune dysregulation) and parenchymal cells (junctional disruption and barrier failure). Created with BioRender.com. Sublethal Membrane Damage in Sepsis: Pathophysiological and Translational Insights As discussed above, sublethal membrane damage is a state in which membrane damage is counterbalanced by the repair system, allowing cells to remain viable despite stress signals. However, direct evidence of sublethal membrane damage in sepsis is limited. Previous studies have focused on traditional cell death in sepsis, rather than transient or reversible membrane injury. Nevertheless, several observations support the possibility of sublethal membrane damage. Two decades ago, Hotchkiss et al found a discrepancy between histological injury and the severity of organ dysfunction in patients who died of sepsis. The percentage of cell death was low, which could not explain the profound organ dysfunction, suggesting that a substantial fraction of cells may remain viable, yet functionally compromised.3,4 The septic microenvironment is particularly favorable for the generation of sublethal membrane injury. Multiple cell death pathways are involved in sepsis, contributing to immunological dysfunction.142 However, inflammatory responses in sepsis are heterogeneous, implying that a fraction of cells may experience sublethal stimulus.143–145 Consistent with such heterogeneity, Sihite et al found that altered serum glutamine levels were associated with disease severity and mortality in sepsis, reflecting the heterogeneous metabolic disturbances of sepsis.146 In parallel, plasma membrane repair systems, particularly ESCRT-III-dependent pathways, are active and can restrain membrane damage in sepsis.23 Together, these conditions may allow some cells to experience sublethal injury without progressing to cell rupture. Sublethal membrane damage may have important consequences on sepsis pathophysiology, even in the absence of traditional cell death. One major outcome is barrier dysfunction. Although sublethal membrane damage may not lead to cell lysis, it disrupts tight junctions between cells, promoting vascular leakage and tissue edema.74 Another consequence is overactivated inflammation. Sublethal immune cells that survive initial lytic signaling remain functionally altered. These cells may continue to produce cytokines and chemokines, contributing to persistent inflammation.25,126 This may explain the coexistence of hyperinflammation and immunoparalysis in sepsis. Apart from barrier damage and immune dysfunction, sublethal membrane damage has been shown to induce tissue fibrosis, which could affect organ function in the long term.126 However, these findings remain largely inferential, and require further validation. From a translational perspective, sublethal membrane damage may provide a therapeutic window before catastrophic membrane injury. Unlike cells undergoing terminal cell death, sublethal cells remain viable and retain the capacity to recover. Therefore, therapeutic strategies targeting sublethal membrane damage should aim not only to block cell death, but also preserve repairable cells and restore their function. Inhibition of NINJ1 may prevent the progression of sublethal injury to irreversible rupture, whereas enhancement of ESCRT-III may promote membrane repair. Modulation of upstream regulators of cell death, including pathway-specific kinases, may also provide benefits, although they are not specific to sublethal membrane damage. In addition, therapeutic strategies that reduce cellular stress may also be relevant. For example, Raihani et al showed that vitamin C attenuated endothelial and cardiac damage, supporting the translational potential of interventions targeting oxidative stress.147 However, translating membrane protection into therapy remains challenging. Whether targeting NINJ1 or ESCRT-III can restore cellular and organ function remains unclear, especially in sepsis. Besides, indiscriminate prevention of cell lysis may interfere with pathogen clearance. In addition, persistent enhancement of membrane repair could theoretically favor the retention of abnormal cells, and whether it contributes to tumorigenesis remains unknown (Table 1). Further studies are therefore warranted to determine the appropriate cell types, timing and extent of membrane protection in sepsis.Table 1Clinical Perspective for Sublethal Membrane DamageClinical PerspectivePotential ExamplesCurrent LimitationBiomarkersDAMPs release with limited LDH release, indicators of membrane permeability and repair activityNo biomarker is currently specific or clinically validated for sublethal membrane damageMembrane-protective targetsNINJ1 inhibition, enhancement of ESCRT-III-mediated repairOptimal timing, cell type, and degree of intervention remain unclearOther therapeutic strategiesGlycine, modulation of Ca2⁺ influx or mechanosensitive ion channels, and other agents reported to limit membrane ruptureMost evidence is preclinical and these interventions are not specific to sublethal injuryDiagnostic strategiesReal-time imaging of membrane permeability and resealing, combined assessment of permeability, viability, and cellular functionTransient membrane damage is difficult to capture in vivoAbbreviations: DAMPs, damage-associated molecular patterns; ESCRT, endosomal sorting complex required for transport; LDH, lactate dehydrogenase; NINJ1, ninjurin-1; Ca2+, calcium ions. Table 1Clinical Perspective for Sublethal Membrane DamageClinical PerspectivePotential ExamplesCurrent LimitationBiomarkersDAMPs release with limited LDH release, indicators of membrane permeability and repair activityNo biomarker is currently specific or clinically validated for sublethal membrane damageMembrane-protective targetsNINJ1 inhibition, enhancement of ESCRT-III-mediated repairOptimal timing, cell type, and degree of intervention remain unclearOther therapeutic strategiesGlycine, modulation of Ca2⁺ influx or mechanosensitive ion channels, and other agents reported to limit membrane ruptureMost evidence is preclinical and these interventions are not specific to sublethal injuryDiagnostic strategiesReal-time imaging of membrane permeability and resealing, combined assessment of permeability, viability, and cellular functionTransient membrane damage is difficult to capture in vivoAbbreviations: DAMPs, damage-associated molecular patterns; ESCRT, endosomal sorting complex required for transport; LDH, lactate dehydrogenase; NINJ1, ninjurin-1; Ca2+, calcium ions. Clinical Perspective for Sublethal Membrane Damage Abbreviations: DAMPs, damage-associated molecular patterns; ESCRT, endosomal sorting complex required for transport; LDH, lactate dehydrogenase; NINJ1, ninjurin-1; Ca2+, calcium ions. Conclusions and Future Perspectives Sublethal membrane damage is emerging as a critical concept for understanding lytic cell death, beyond the traditional binary view. In pyroptosis, necroptosis, and ferroptosis, plasma membrane injury does not always lead to rupture. Instead, when plasma membrane damage is transient or limited and repair mechanisms are sufficient, cells may present a sublethal state. Accumulating evidence has suggested that sublethal membrane damage is not biologically silent. Even in the absence of cell rupture, it can promote inflammatory signaling, disrupt barrier integrity, and contribute to long-term tissue remodeling. Although direct evidence remains limited, sepsis appears to be highly permissive to the occurrence of sublethal membrane damage. This framework may help explain the discrepancy between severe organ dysfunction and relatively limited cell death observed in sepsis. Future studies should aim to define sublethal membrane damage as a measurable and biologically meaningful state in sepsis. In vivo approaches are required to capture transient membrane permeabilization and repair across different tissues and cell types. Additionally, clarifying the molecular mechanisms that lead to sublethal membrane damage is important. Ultimately, a deeper understanding of this process may enable therapeutic strategies that go beyond simply blocking cell death by preserving recoverable cells, enhancing membrane repair and limiting the consequences induced by sublethal membrane damage. By shifting the focus from membrane rupture alone to sublethal membrane damage, future research may offer a better framework for understanding and treating sepsis.